People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Schwetz to lead OHRP: Bernard Schwetz, PhD/DVM, is named permanent director of the HHS Office for Human Research Protections April 8, after serving in an acting capacity since February 2003. The former FDA senior adviser plans to work toward developing better communications with the public as well as with the human subjects research community. Schwetz also will try to provide more OHRP guidance on the interpretation of HHS regulations. At the most recent meeting of the Secretary's Advisory Committee on Human Research Protections, for which he is executive secretary, Schwetz agreed with panel members that OHRP and FDA should develop official guidance on research adverse event reporting...
You may also be interested in...
Aspect Medical Eyes Profitability Through BIS Extension, OEM Integration
The recent approval of Aspect Medical's BISx integration technology is a "critical step" in the firm's efforts to "BIS-enable" future patient monitoring systems introduced to the U.S. market, President & CEO Nassib Chamoun told analysts April 22
Aspect Medical Eyes Profitability Through BIS Extension, OEM Integration
The recent approval of Aspect Medical's BISx integration technology is a "critical step" in the firm's efforts to "BIS-enable" future patient monitoring systems introduced to the U.S. market, President & CEO Nassib Chamoun told analysts April 22
CDRH Leadership Changes May Be Imminent; NCI’s Ellen Feigal To Leave Institute
FDA is vetting a list of more than 20 candidates for a CDRH clinical deputy spot - a position that may grow in stature with the potential departure of Director David Feigal